U.S. endocrine-focused pharmaceutical development and commercialization firm Crinetics Pharmaceuticals has confirmed an ongoing investigation into a cybersecurity incident claimed by the LockBit ransomware operation.
Article Link: Crinetics Pharmaceuticals cyberattack under investigation | SC Media